Chuang-Chuang Ángela, Baeza María A
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile. Email:
Proyecto Epistemonikos, Santiago, Chile; Departamento de Otorrinolaringología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Medwave. 2017 Mar 13;17(Suppl1):e6863. doi: 10.5867/medwave.2017.6863.
Ménières disease affects the inner ear and its main symptoms are vertigo, hearing loss and fluctuating aural symptoms. Nowadays, there are many therapeutic alternatives, being the use of intratympanic corticosteroids one that has become popular. To answer this question, we searched in Epistemonikos database, which is maintained by screening multiple databases. We identified four systematic reviews including 15 studies overall, of which seven were randomized trials. We extracted data and generated a summary of findings table using the GRADE approach. We concluded intratympanic corticosteroids probably do not decrease tinnitus, and might not decrease vertigo, hearing loss or aural fullness sensation in Ménières disease. Intratympanic corticosteroids probably do not cause important adverse effects.
梅尼埃病影响内耳,其主要症状为眩晕、听力损失和波动性耳部症状。如今,有许多治疗选择,鼓室内注射皮质类固醇的使用已变得流行。为回答这个问题,我们在由多个数据库筛选维护的Epistemonikos数据库中进行了检索。我们确定了四项系统评价,共纳入15项研究,其中七项为随机试验。我们提取数据并使用GRADE方法生成了结果总结表。我们得出结论,鼓室内注射皮质类固醇可能不会减轻梅尼埃病患者的耳鸣,也可能不会减轻眩晕、听力损失或耳部胀满感。鼓室内注射皮质类固醇可能不会引起严重不良反应。